Based on our forecasts, a long-term increase is expected, the "MRNA" stock price prognosis for 2026-05-08 is 366.718 USD. Moderna. Revenue grew 22,989.8% on a year-over-year basis. Estimated earnings for the last four quarters. Moderna Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MRNA earnings call for the period ending March 31, 2021. Moderna said its Covid-19 vaccine is 96% effective in kids ages 12 to 17, according to early data released with the company's first-quarter earnings Thursday. See Moderna, Inc. (MRNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 's earnings in 2021 is $598,166,000.. On average, 9 Wall Street analysts forecast MRNA's earnings for 2021 to be $9,599,786,903, with the lowest MRNA earnings forecast at $5,376,900,878, and the highest MRNA earnings forecast at $12,484,804,046. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast. ... we are raising our forecast for capital investment from our previous range of $350 … The consensus earnings estimate was $2.04 per share on revenue of $2.2 billion. Moderna, Inc. (MRNA) stock forecast and price target. With a 5-year investment, the revenue is expected to be around +144.66%. Earnings Estimates are available only for US equities. In the same quarter last year, Moderna's earnings per share (EPS) was -$0.35. Moderna (NASDAQ:MRNA) is scheduled to announce Q1 earnings results on Thursday, May 6th, before market open. Find the latest Moderna, Inc. MRNA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Moderna (MRNA) reported 1st Quarter March 2021 earnings of $2.84 per share on revenue of $1.9 billion. MRNA updated stock price target summary. This table is designed to uncover Earnings Surprises — times when a stock's earnings either out-perform or under-perform the analysts' expectations. Total Moderna earnings for the quarter were $1.22 billion. The first table on the Estimates page compares Actual vs. Last 3 Quarters for MRNA … On May 06, 2021, Moderna (NASDAQ: MRNA) reported Q1 2021 earnings per share (EPS) of $3.05, up 971.43% year over year. >Earnings Surprises.